Overview

Extended-dose Chloroquine (ECQ) for Resistant Falciparum Malaria Among Afghan Refugees in Pakistan

Status:
Completed
Trial end date:
1995-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to provide stronger evidence for extended-dose chloroquine treatment of falciparum-positive Afghan refugees in Northwest Frontier Province (NWFP), Pakistan or justification for discontinuation of the policy.
Phase:
Phase 4
Details
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborators:
European Union
United Nations High Commissioner for Refugees
World Health Organization
Treatments:
Chloroquine
Chloroquine diphosphate